Human SNP ID | rs17022444 |
---|---|
Human chromosome | chr2 |
Human SNP position | 82802345 |
Pig chromosome | chr3 |
Pig SNP position | 64493516 |
PubMed ID | 19875103 |
---|---|
Journal | Biol Psychiatry |
Link | www.ncbi.nlm.nih.gov/pubmed/19875103 |
Study | Genomewide association study of movement-related adverse antipsychotic effects. |
Disease/Trait | Response to antipsychotic therapy (extrapyramidal side effects) |
Initial sample | 421 European ancestry schizophrenia cases, 214 African American schizophrenia cases, 103 schizophrenia cases |
Replication sample | NA |
Region | 2p12 |
Chromosome id | chr2 |
Chromosome position | 82802345 |
Reported gene | intergenic |
Mapped gene | LOC105374830 - LOC105374831 |
Upstream gene id | 105374830 |
Downstream gene id | 105374831 |
SNP gene ids | |
Upstream gene distance | 377846 |
Downstream gene distance | 23648 |
SNP risk allele | rs17022444-? |
SNPs | rs17022444 |
Merged | 0 |
SNP id current | 17022444 |
Context | intergenic_variant |
Intergenic | 1 |
Allele frequency | NR |
P value | 0.0000000001 |
Pvalue mlog | 10 |
P value text | (SAS) |
Or beta | |
%95 Ci | |
Platform | Affymetrix [492000] |
CNV | N |
Mapped trait | response to antipsychotic drug |
Mapped trait URI | http://purl.obolibrary.org/obo/GO_0097332 |
Study accession | GCST000514 |